With emerging drug resistance, ciprofloxacin became the frontline antibiotic against Salmonella strains causing enteric fevers worldwide. However, strains with decreased susceptibility to flouroquinolones have recently emerged as a problem in our region. Such strains are not detected by the routine disc diffusion method unless a nalidixic acid disc is also used. They are, however, important clinically since they show poor clinical responses and have higher faecal carriage rates following treatment with fluoroquinolones in usual doses. We report the first two cases of such strains in Sri Lanka, both acquired locally. We recommend the routine use of a nalidixic acid disc in sensitivity testing of Salmonella species, causing enteric fever in laboratories not determining minimum inhibitory concentrations (MICs) for fluoroquinolones in order to detect such strains, so that appropriate clinical decisions regarding antibiotic therapy can be made.
Introduction
Enteric fevers are a group of systemic infections caused by invasive Salmonella species, classically Salmonella typhi but also S. paratyphi A, S. shottmulleri (formerly S. paratyphi B) and S. hirschfeldii (formerly S. paratyphi C) [1] . Chloramphenicol was its firstline therapy for many years until antibiotic resistance became a global problem with the emergence of multi-drug resistant S. typhi [2] . Randomised controlled trials have shown that ciprofloxacin is the most effective drug, and resistance rarely emerged during its use. The average fever Enteric fever caused by Salmonella isolates with decreased susceptibility to ciprofloxacin (Index words: Antibiotic sensitivity, nalidixic acid disc, poor response to fluoroquinolones) clearance time was less than 4 days and cure rates over 96%, and less than 2% developed persistent faecal carriage or relapse [2] .
In Sri Lanka, chloramphenicol was considered as the most appropriate antibiotic against S. typhi until recently. But 43% of isolates were resistant to chloramphenicol by 1999, with increasing resistance to ampicillin, mecillinam and cotrimoxazole, and sensitive to ciprofloxacin and ceftriaxone [3] . In Asia, S typhi strains with decreased susceptibility to fluoroquinolones have become a major problem in recent times [2] . Although these strains were reported as susceptible to ciprofloxacin by the disc diffusion method, they were nalidixic acid-resistant. Their MIC to fluoroquinolones (0.125-1mg/L) was 10 times higher than that of fully susceptible strains [2] .
We report the first two cases of enteric fever with reduced susceptibility to ciprofloxacin identified by disc diffusion method in Sri Lanka.
Case histories
S. typhi and S. paratyphi A were isolated from the blood from two patients. Both patients were clinically suspected to have enteric fever, and had no history of travel outside Sri Lanka. Identification was done using standard culture techniques and confirmed serologically. Both patients had shown a poor clinical response to ciprofloxacin. Table 1 shows their antibiotic susceptibility patterns. 
Discussion
Decreased susceptibility to fluoroquinolones among Salmonella strains causing enteric fever is a problem for the clinician and the laboratory, unlike fully resistant strains. Laboratories using the disc diffusion method for determining antibiotic sensitivity in vitro may report them as susceptible to fluoroquinolones. But patients infected with them may show a poor clinical response to fluoroquinolones. They may have longer fever clearance time and higher convalescent faecal carriage rate. In addition, they usually show multi-drug resistance [2] .
In laboratories where MICs cannot be performed, the concurrent use of a 30 µg nalidixic acid disc in disc diffusion antibiotic susceptibility testing is therefore important, until newer criteria for fluoroquinolone resistance evolve. Strains that are nalidixic acid-resistant should be reported as having decreased susceptibility to fluoroquinolones [2] . For such strains, oral azithromycin or higher doses of ciprofloxacin may be given if the patient has uncomplicated enteric fever, or ceftriaxone parenterally in severe cases [2] . Chloramphenicol, amoxicillin or cotrimoxazole can be given if the isolate is fully susceptible and a more effective drug is not available or is unaffordable.
